Hodgkinson, Roy G. Beran, Dennis J. Cordato
In this randomized controlled trial, biofeedback was examined for its ability
to improve emotional well-being in patients with relapsing-remitting MS. Two
groups of patients received treatment consisting of relaxation, mindfulness,
social support, and education, and one of the groups also received biofeedback
designed to regulate the physiological stress response. Both groups showed
reductions in anxiety, fatigue, and stress; patients in the biofeedback group
also demonstrated significant reductions compared to the control group in
physiological measurements of breathing rate and muscle tension.